Even Healthcare 50 Million Series B Explained: Khosla's Bet on Hospitals That Profit When Patients Get Better (India Tech)

even healthcare 50 million series b explained — a modern hospital building seen from above (illustrative photo, not an Even hospital)

Illustrative image: a modern hospital building. No official photograph of an Even hospital exists in the round's coverage, so this is a stock hospital photo, not an Even facility. Image: Wikimedia Commons / Dietmar Rabich, CC BY-SA 4.0

TL;DR: Even Healthcare 50 million Series B explained: Bengaluru's managed-care startup raised $50 million (about ₹474 crore) led by Khosla Ventures, valuing it at a reported $300 million — triple its value 18 months ago. The money builds five new Even hospitals in Bengaluru, on a model where doctors are paid salaries, not per procedure, so the company profits when patients get better, not when they get more treatment.

📌 KEY HIGHLIGHTS

  • $50 million Series B, all equity: led by existing investor Khosla Ventures, with Alpha Wave participating; total funding now over $120 million.
  • Reported $300 million valuation: triple the value of 18 months ago — though Even itself has publicly said only that valuation "tripled".
  • Five new Bengaluru hospitals: planned over the next six months, starting in Indiranagar, on top of the two Even hospitals already running.
  • The model flip: salaried doctors, no pay tied to procedure volume, and one care team following each member — designed to remove the incentive for unnecessary tests and surgeries.
  • Biggest cheque of India's funding week: Indian startups raised about $184 million across 17 deals in the week of 19–23 October, and Even's round was the largest single deal.

What happened?

Bengaluru-based Even Healthcare announced on 19 October 2026 that it had raised $50 million — around ₹474 crore — in a Series B round led by Khosla Ventures, the Silicon Valley firm that has backed Even since its seed round in 2021. Alpha Wave joined the round. The company said the round tripled its valuation from its previous fundraise 18 months earlier and pushed its total funding beyond $120 million.

Coverage of the round puts the valuation at around $300 million. That figure is worth stating carefully: Even's own announcement says "tripled", and the $300 million number comes from reporting on the round, including TechCrunch. It is the best available figure, not a number Even has itself confirmed in so many words.

The money has a concrete destination. Even will build five new hospitals across Bengaluru over the next six months, starting with Indiranagar. Co-founder and CEO Mayank Banerjee framed the ambition plainly: an Even hospital within five kilometres of every family in Bengaluru, and then the same model in every major Indian city.

Even Healthcare 50 million Series B explained: the deal in numbers

DetailWhat we know
RoundSeries B, $50 million (~₹474 crore), all equity
Lead investorKhosla Ventures (existing investor, backed Even since its 2021 seed round)
Other investorAlpha Wave
ValuationReported ~$300 million; Even says only that valuation "tripled" in 18 months
Total funding to dateOver $120 million
Use of fundsFive new hospitals in Bengaluru over six months, starting in Indiranagar
Members250,000+ across 10 cities (company-reported)
Hospitals todayTwo running in Bengaluru, a third close to opening (company-reported)
FoundersMayank Banerjee (co-founder & CEO), Matilde Giglio, Alessandro Ialongo

even healthcare 50 million series b explained — a modern hospital building exterior (illustrative photo, not an Even hospital)

Illustrative image: a modern hospital building in Derry/Londonderry. Even's own hospitals are in Bengaluru; this photo shows the kind of facility the model is built around. Image: Wikimedia Commons / Kenneth Allen, CC BY-SA 2.0

Why the model is different: doctors paid for outcomes, not procedures

The usual private-hospital economics in India run the other way. A hospital generally earns more when a patient gets more tests, more procedures and more days in a bed — even when some of that care is not strictly needed. Even's bet is that this incentive is the disease, and its business model is the treatment.

Even runs a membership-based managed-care service that bundles preventive care, consultations, diagnostics, insurance access, hospitalisation and recovery under one roof, with one care team following each member over time. Its doctors and hospital managers draw fixed salaries rather than pay tied to procedure volume, and every employee holds equity in the company. When a member needs hospital care, it is cashless, delivered by doctors with no financial incentive to recommend a procedure the patient does not need — and after discharge, the same team stays in touch until recovery is complete.

The reason Even builds its own hospitals, Banerjee has said, is that partner hospitals kept failing that test: Even found patients being steered toward tests or surgeries it considered unnecessary. Owning the hospital lets Even control the decision, the cost and the follow-up. Khosla Ventures founder Vinod Khosla put the firm's conviction this way: "The clinical and economic results so far give us conviction that this can become an important new model for healthcare in India and beyond."

The results Even cites are striking, and they are all company-reported, not independently audited: unplanned hospital readmissions under 1%, against a sector benchmark of 8–15%; hospital stays 40% shorter; and over ₹500 million saved for insurers so far. Its first two Bengaluru hospitals each turned profitable, excluding depreciation, within a year of opening. Treat those numbers as the company's case for itself — the five new hospitals are the test of whether they scale.

Why it matters for India readers

For Indian readers, this is a funding story that touches a bill almost every family dreads: the unpredictable hospital bill. If Even's model works at city scale, it offers a template where the hospital's profit and the patient's recovery point in the same direction — fewer surprise scans, fewer "just in case" procedures, one team accountable from first consultation to final follow-up. That is a genuinely different promise from the discount-and-cashback health plans that dominate the market.

The week's funding data backs the timing. Indian startups raised about $184 million across 17 deals in the week of 19–23 October, down from $236 million the week before — and Even's $50 million was the single biggest cheque, ahead of a $48 million seed round for AI-marketing startup Different. Healthtech took $60.6 million across just two deals. In a week when AI took half of all funding, the largest bet went to hospitals, not models.

There is also a harder chapter the round does not erase. Outlets including Inc42 and Entrepreneur India reported in August 2026 that Even cut around 350 employees — roughly 30–35% of its workforce — as it shifted from an insurance-led approach to a hospital-led one. Even did not confirm those figures. The layoffs, if accurate, are part of the same pivot the new funding now finances: fewer people selling plans, more concrete, beds and salaried doctors. Readers should weigh both halves of that story.

Should you care?

✅ Yes — if you live in Bengaluru or follow Indian healthtech: five Even hospitals in six months will show quickly whether outcome-based care survives contact with real scale. Watch the Indiranagar opening and whether the readmission and stay-length numbers hold outside Even's early member base. ⏳ Wait for proof if you are elsewhere: the model is Bengaluru-only for now, and the "every major city" expansion is an ambition, not a timeline. 🔍 Honest caveat: the $300 million valuation is reported, not confirmed by Even as a number, and every outcome statistic in this post is company-reported. The funding is real; the model is still proving itself. For a different flavour of this week's startup money, read our Blacksmith $66 million Series C and Daytona $60 million Series B stories, or the Tractian $130 million Series D explainer.

FAQs

How much did Even Healthcare raise in its Series B?
Even Healthcare raised $50 million (about ₹474 crore) in an all-equity Series B round led by existing investor Khosla Ventures, with Alpha Wave participating. The round takes its total funding to more than $120 million.

What is Even Healthcare's business model?
Even runs a membership-based managed-care service in Bengaluru covering preventive care, consultations, diagnostics, insurance access, hospitalisation and recovery. Its doctors are salaried rather than paid per procedure, so the company says it profits from better patient outcomes, not from more treatment.

What is Even Healthcare's valuation after the Series B?
Coverage of the round reports a valuation of around $300 million, triple its value 18 months earlier. Even itself has publicly said only that its valuation tripled; it has not confirmed the $300 million figure as its own number.

Is Even Healthcare available outside Bengaluru?
Not yet as a hospital operator: its hospitals are in Bengaluru, though it reports members across 10 cities. The company says it aims to put an Even hospital within five kilometres of every Bengaluru family first, then expand the model to other major Indian cities — but it has given no dates for that expansion.

Takeaway: Khosla Ventures just paid $50 million for a simple idea — that a hospital should make money when patients get better, not when they get more treatment. Bengaluru's next five hospitals will show whether that idea scales.

Follow India Tech on TechByCountry for tomorrow's update.

📸 Get tech in the last 24 hours on Instagram — follow @_techinlast24hrs for daily posts (9 AM–9 PM) and reels at 12:30 PM & 8:30 PM.

Sources

Comments